Man Group PLC Citius Pharmaceuticals, Inc. Transaction History

Man Group PLC

  • $38.1 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.78 - $1.42 $67,559 - $122,993
86,615 Added 187.43%
132,826 $155,000
Q4 2022

Feb 14, 2023
BUY
$0.79 - $1.23 $26,635 - $41,470
33,716 Added 269.84%
46,211 $36,000
Q3 2022

Nov 14, 2022
BUY
$0.14 - $1.33 $1,749 - $16,618
12,495 New
12,495 $15,000

Others Institutions Holding CTXR

# of Institutions
70
Shares Held
26.7M
Call Options Held
0
Put Options Held
0
View Full List

About Citius Pharmaceuticals, Inc.

CTXR Quotes by TradingView
  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $140M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email